A Simple Scan with Profound Implications
In the constant battle against diabetes—a disease that affects hundreds of millions globally—early detection remains one of the most powerful weapons. Now, researchers at Michigan Medicine are exploring a surprisingly simple yet potentially game-changing tool: the muscle ultrasound. According to their latest study, scanning a patient’s thigh or shoulder muscle may detect insulin resistance long before it evolves into full-blown type 2 diabetes or even prediabetes.
This approach builds on an intriguing observation by Dr. Steve Soliman, D.O., RMSK, FAIUM, FAOCR, director of MSK ultrasound and the MSK radiology fellowship at the University of Michigan. “We perform a large number of shoulder ultrasounds and noticed that many patients’ muscles appear unusually bright,” he explained. “We found it interesting that most of these patients have type 2 diabetes. Seeing this pattern, we often thought, ‘This patient must have diabetes.’ More importantly, many were unaware of their condition until we verified with their electronic records and confirmed with their bloodwork.”
Early Clues Hidden in Bright Muscles
In this recent study, researchers performed muscle ultrasounds on 25 participants while simultaneously measuring their insulin resistance using the gold-standard insulin clamp technique. Two trained research assistants independently analyzed the images and identified increased muscle echo intensity—essentially, brighter muscles—in all eight subjects who were confirmed to have insulin resistance and all seven who showed impaired insulin sensitivity.
Remarkably, this meant a “potential 100% accuracy in identifying individuals with these conditions,” as noted in the study. Even more striking, some patients had no prior signs of diabetes or prediabetes on blood tests, yet their muscle ultrasounds revealed abnormalities. Short-term follow-ups often confirmed these individuals developed prediabetes or type 2 diabetes soon after.
This pattern suggests that muscle brightness on ultrasound may flag metabolic changes earlier than traditional blood markers can detect. “This noninvasive tool could detect insulin resistance, which can precede type 2 diabetes by many years, or even decades,” Soliman emphasized.
Addressing a Global Challenge
Globally, the need for earlier and more accessible diabetes screening cannot be overstated. The study highlights that around 232 million people with type 2 diabetes and another 438 million with prediabetes remain undiagnosed worldwide—representing about 50% and 81% of their respective populations. In the United States alone, nearly 100 million people fall into this undiagnosed category, with underserved communities disproportionately affected.
The stakes are high: by the time diabetes is officially diagnosed, approximately half of patients already suffer irreversible complications such as nerve damage, kidney disease, or vision loss. Detecting insulin resistance years in advance could open a critical window for lifestyle intervention and medical management before permanent damage occurs.
Understanding the Science Behind the Brightness
While the correlation between brighter muscles and insulin resistance is compelling, the precise biological cause remains under investigation. Initial muscle biopsy findings suggest that the increased echo intensity seen in ultrasounds might be linked to excessive fat infiltration within muscle tissue, as well as fibrosis—scarring that may compromise muscle health and function.
Interestingly, although ultrasound brightness clearly indicates insulin resistance, researchers found no direct correlation between brightness levels and the exact degree of insulin resistance as measured by the clamp test’s M values. This suggests that while ultrasound can flag the presence of a problem, it may not quantify its severity—at least not yet.
Dr. Soliman and his team believe this gap may be due to the study’s small sample size and are actively enrolling more participants to deepen the analysis and validate findings across a broader population.
A Vision for Accessible, Noninvasive Screening
One of the most promising aspects of this research is its potential to make early screening widely accessible. Unlike lab-based insulin clamp tests, which require specialized equipment and expertise, muscle ultrasound is simple, noninvasive, cost-effective, and free of radiation exposure.
“Clinicians increasingly use these point-of-care and handheld ultrasound devices, sometimes called ‘the stethoscope of the future,’ for rapid diagnosis of various conditions,” Soliman noted. With advances in artificial intelligence and machine learning, these devices could automatically analyze muscle brightness, flagging patients as high or low risk with minimal human interpretation.
“A medical assistant or clinician with little to no training could easily use this device on a patient’s upper arm or thigh, as routinely as checking weight or blood pressure, and potentially flag patients as ‘high risk’ or ‘low risk’ for further testing,” he added. This could enable routine metabolic screening in diverse settings—from urgent care clinics to pharmacies, community health fairs, or even remote areas with limited healthcare infrastructure.
Next Steps and the Road Ahead
While the initial results are highly encouraging, researchers caution that larger studies are necessary to confirm accuracy, understand variability, and refine best practices for integrating muscle ultrasound into standard care pathways.
Furthermore, unlocking the precise biological mechanisms behind muscle brightness could pave the way for targeted therapies aimed at reversing early tissue changes and halting diabetes progression at its root.
Nonetheless, the study’s message is clear: by transforming a routine imaging tool into a window for metabolic health, muscle ultrasound holds the promise of catching diabetes before it wreaks irreversible harm.
For millions at risk worldwide, this could mean earlier intervention, better outcomes, and ultimately, a significant reduction in the global burden of diabetes—a goal that resonates with public health leaders, clinicians, and patients alike.
Thus, a simple ultrasound—long trusted to image bones and tendons—may soon emerge as a frontline guardian against one of the world’s most pervasive chronic diseases.
Recommended For You
